Profil is the leading full-service CRO specializing exclusively in clinical research focused on diabetes, obesity, and related conditions. With a strong emphasis on driving innovation in diabetes treatment, Profil has established itself as the world's top diabetes and obesity CRO. Their expertise lies in patient-initiated research, where they actively collaborate with patients to develop effective diabetes treatments and alternative insulins.

Profil also conducts extensive research into diabetes complications, such as obesity and prediabetes, impaired glucose tolerance, and comorbidities like NAFLD/NASH. In addition to their clinical trial services, Profil offers a range of specialized methods for accurate data collection, including glucose clamps, body composition analysis, and metabolic flux studies. They also provide further services such as patient recruitment, GMP-certified pharmacy, data management, statistics, medical writing, and regulatory handling.

With their dedication to scientific excellence and patient-focused approach, Profil is at the forefront of advancing diabetes and obesity research and treatment